Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy
| Published in: | Haematologica |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2012-09-01
|
| Online Access: | https://haematologica.org/article/view/6417 |
